Showing 1731-1740 of 2494 results for "".
- Johnson & Johnson to Debut EYE-RD Global Registry at ARVOhttps://modernod.com/news/johnson-johnson-to-debut-eye-rd-global-registry-at-arvo/2482261/Johnson & Johnson announced that eight company-sponsored presentations will be featured during the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting taking place in Seattle from May 5–9, 2024. The company's two oral presentations wil
- Bausch + Lomb Presents New Data at the Association for Research in Vision and Ophthalmology Annual Meetinghttps://modernod.com/news/bausch-lomb-presents-new-data-at-the-association-for-research-in-vision-and-ophthalmology-annual-meeting/2482250/Bausch + Lomb announced the presentation of 21 scientific poster presentations during the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, which will take place in Seattle on May 5-9, 2024. The posters highlight the results of studies evaluating consumer,
- Bausch + Lomb to Present Scientific Data and Analyses on Xipere at Macula Society Annual Meetinghttps://modernod.com/news/bausch-lomb-to-present-scientific-data-and-analyses-on-xipere-at-macula-society-annual-meeting/2482098/Bausch + Lomb announced it will feature two podium presentations on Xipere during the Macula Society annual meeting, which will take place in Palm Springs, California, Feb. 7-10, 2024. One presentation will highlight the results of a study assessing the durability of Xipe
- Haag-Streit Announces Winners of its Slit Lamp Imaging Competition 2023https://modernod.com/news/haag-streit-announces-winners-of-its-slit-lamp-imaging-competition-2023/2481881/Attracting over 350 images from around the world, Haag-Streit Announced its top three winners of its Slit Lamp Imaging Competition 2023. The winners were judged on on image quality, technical execution, and disease interest. • First place: Pia Emilia Lohr
- Bausch + Lomb Launches New Range of Pure‐Line Gases at Euretinahttps://modernod.com/news/bausch-lomb-launches-new-range-of-pureline-gases-at-euretina-1/2481869/Bausch + Lomb announced the European launch of the new range of Pure‐line gases during the European Society of Retina Specialists (Euretina) annual meeting, taking place in Amsterdam, The Netherlands, Oct. 5‐ 8, 2023. Designed for ease of use, the Pure‐line gases are available as both p
- Oculis to Present a Late-Breaking Abstract at Euretina on Phase 3 Stage 1 DIAMOND Trial Results for Diabetic Macular Edemahttps://modernod.com/news/oculis-to-present-a-late-breaking-abstract-at-euretina-on-phase-3-stage-1-diamond-trial-results-for-diabetic-macular-edema/2481867/Oculis announced that the positive readout from Stage 1 of its phase 3 DIAMOND trial of OCS-01 in patients with diabetic macular edema (DME) will be presented as a late-breaking abstract at the 23rd Euretina Congress, taking place October 5-8, 2023 in Amsterdam, the Netherlands.
- Nanoscope Therapeutics Announces Presentations at Upcoming Conferenceshttps://modernod.com/news/nanoscope-therapeutics-announces-presentations-at-upcoming-conferences/2481862/Nanoscope Therapeutics, which is developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), is scheduled to participate in the 2023 Ophthalmology Futures Retina Forum and Euretina Innovation Spotlight at the 23rd Euretina Congress, each taking place
- Rayner Completes First Implantations of IOLs in Clinical Trials in China and the UShttps://modernod.com/news/rayner-achieves-milestone-implantations-in-clinical-trials-in-china-and-the-us/2481774/Rayner has announced the completion of the first implantations in two pivotal market access studies in the US and China. Rayner's RayOne EMV Toric IOL received investigational device exemption (IDE) approval from the FDA in June. The first study implantation took place at
- Annexon to Report ARCHER Phase 2 Trial Results in Geographic Atrophy at ASRShttps://modernod.com/news/annexon-to-report-archer-phase-2-trial-results-in-geographic-atrophy-at-asrs/2481746/Annexon announced the company will present results from the ongoing ARCHER phase 2 trial in patients with geographic atrophy (GA) at the American Society of Retina Specialists (ASRS) 2023 annual meeting taking place July 28-August 1,
- Ciliatech Presents 2-Year Postoperative Results on New Cilio-Scleral Surgical Approach for Treating Glaucomahttps://modernod.com/news/ciliatech-presents-2-year-postoperative-results-on-new-cilio-scleral-surgical-approach-for-treating-glaucoma/2481698/Ciliatech announced it will present the preliminary results of the second 2-year postoperative clinical trial (SAFARI II) on its Cilia-scleral Interposition Device (CID) during the World Glaucoma Congress, taking place this week. Ciliatech will present results showing sta